BioSpace News Archive

The coronavirus is transmitted mainly by postilions and droplets of water propelled by the infected person to his entourage. However, on July 6, 2020, a group of 239 international scientists called on health authorities aroun

Contrast-enhanced ultrasound (CEUS) helps physicians accurately diagnose some forms of liver cancer -- and does so more safely and less expensively than computed tomography (CT) and magnetic resonance (MR), according to a report just published in Hepatoma Research.

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

LB Pharmaceuticals Inc, (“LB”, or the “Company”), a biotechnology company focused on developing and commercializing novel and improved versions of successful CNS treatments, today announced the results of a Phase 1 clinical study of LB-102 (NCT04187560), a novel derivative of amisulpride designed to treat schizophrenia

Fibralign Corp., a Stanford spin-out and developer of therapeutic biomedical devices, today announced that it has received CE mark for its first product, the BioBridge® Collagen Matrix. BioBridge is classified as a Class III device with an indication for use to support lymphatic tissue repair and can be used after or in conjunction